ReFlow Medical Inc. announced U.S. Food and Drug Administration (FDA) clearance for commercialization of their SpeX shapeable support catheter in the United States for use in the peripheral vasculature, as well as the first American clinical cases with the device. The initial United States cases were performed by John R. Laird, M.D., at the University of California-Davis Vascular Center.

The U.S. Food and Drug Administration (FDA) cleared a new screening test that predicts a patient’s risk of future coronary heart disease (CHD) events, such as heart attacks.